Jianqiang Yang

Jianqiang Yang

Auto-generated profile, based on publicly available information

Jianqiang Yang

Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JYJianqiang Yang
Jianqiang Yang
FCFanghui Chen
Fanghui Chen
LLLiwei Lang
Liwei Lang
FYFan Yang
Fan Yang
ZFZhenzhen Fu
Zhenzhen Fu
Yong TengYong Teng
Yong Teng
Head and neck squamous cell carcinoma (HNSCC) is addicted to glutaminolysis. Targeting this metabolic dependency has emerged as a potential therapeutic approach for HNSCC. In this study, we conducted a bioinformatic analysis of The Cancer Genome Atlas HNSCC cohort that revealed a robust correlation between expression of MYC (encoding the protein c-Myc) and glutaminase 1 (GLS1), which catalyzes the first step in glutaminolysis. Intriguingly, disruption of GLS1 signaling in HNSCC cells by genetic depletion or CB-839 treatment resulted in a reduction in c-Myc protein stability via a ubiquitin-specific peptidase 1–dependent ubiquitin–proteasome pathway. On the other hand, c-Myc directly binds to the promoter region of GLS1 and upregulates its transcription. Notably, the GLS1–c-Myc pathway enhanced acetyl-coenzyme A carboxylase–dependent Slug acetylation, prompting cancer cell invasion and metastasis. Thus, the GLS1–c-Myc axis emerged as a positive feedback loop critical for driving the aggressiveness of HNSCC. Therapeutically, combining CB-839 with the c-Myc inhibitor MYCi975 strongly suppressed GLS1–c-Myc signaling, resulting in a superior antitumor effect compared with either single agent in an orthotopic mouse model of HNSCC. These findings hold promise for the development of effective therapies for patients with HNSCC, addressing an urgent need arising from the significant incidence and high metastatic rate of the disease. Significance: GLS1 and c-Myc form a positive feedback loop that promotes head and neck cancer metastasis and can be targeted as a promising therapeutic strategy for this disease.

13 September 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
JYJianqiang Yang
Jianqiang Yang
BWBaoxin Wang
Baoxin Wang
YWYating Wang
Yating Wang
CFChen Feng
Chen Feng
LCLixiao Chen
Lixiao Chen
PDPin Dong
Pin Dong
Peripheral nerve injury (PNI) is often resulting from trauma, which leads to severe and permanently disability. Schwann cells are critical for facilitating the regeneration process after PNI. Adipose-derived mesenchymal stem cells (ADSCs) exosomes have been used as a novel treatment for peripheral nerve injury. However, the underlying mechanism remains unclear. In this study, we isolated ADSCs and extracted exosomes, which were verified by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blot (WB). Cocultured with Dorsal Root Ganglion (DRG) and Schwann cells (SCs) to evaluate the effect of exosomes on the growth of DRG axons by immunofluorescence, and the proliferation and migration of SCs by CCK8 and Transwell assays, respectively. Through exosomal miRNA sequencing and bioinformatic analysis, the related miRNAs and target gene were predicted and identified by dual luciferase assay. Related miRNAs were overexpressed and inhibited, respectively, to clarify their effects; the downstream pathway through the target gene was determined by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) and WB. Results found that ADSC-exosomes could promote the proliferation and migration of SCs and the growth of DRG axons, respectively. Exosomal miRNA-22-3p from ADSCs directly inhibited the expression of Phosphatase and Tensin Homolog deleted on Chromosome 10 (PTEN), activated phosphorylation of the AKT/mTOR axis, and enhanced SCs proliferation and migration. In conclusion, our findings suggest that ADSC-exosomes could promote SCs function through exosomal miRNA-22-3p, which could be used as a therapeutic target for peripheral nerve injury.

28 April 2025 in Cancer Research
Verified
Journal Article
Closed access
JYJianqiang Yang
Jianqiang Yang
FCFanghui Chen
Fanghui Chen
ZFZhenzhen Fu
Zhenzhen Fu
FYFan Yang
Fan Yang
Nabil SabaNabil Saba
Nabil Saba
Yong TengYong Teng
Yong Teng
The tricarboxylic acid (TCA) cycle is often rewired or dysregulated to meet the increased energy and biosynthetic demands of rapidly dividing cancer cells, and targeting the TCA cycle is a potential therapeutic strategy for treating cancer. However, tumor cell metabolism can impact other cells in the tumor microenvironment, and disrupting the TCA cycle in cancer cells could impact the antitumor immune response. In this study, using CPI-613 as a model drug for TCA cycle inhibition, we identified a molecular mechanism by which blocking the TCA cycle enhances T-cell–mediated antitumor immunity in the context of head and neck squamous cell carcinoma (HNSCC). Impairment of mitochondrial metabolism by CPI-613 induced endoplasmic reticulum stress in HNSCC cells, leading to increased expression of spliced X-box–binding protein 1. This, in turn, directly suppressed the transcriptional activity of the thrombospondin-2 gene. Correspondingly, CPI-613 reduced the secretion of thrombospondin-2 from HNSCC cells, enhancing the proliferation and cytotoxic potential of tumor-infiltrating CD36+CD8+ T cells by upregulating AKT-mTOR signaling. This mechanism ultimately enhanced antitumor immunity in a syngeneic mouse model of orthotopic HNSCC following CPI-613 treatment. These findings uncover the immunomodulatory role of the TCA cycle in cancer cells and suggest that targeting it is a promising approach to harness tumor-reactive immune cells. Significance: The immunomodulatory role of the TCA cycle in cancer cells provides a therapeutic opportunity to enhance antitumor immunity by targeting tumor cell metabolism.


2 June 2025
Verified
Other
Open access
JYJianqiang Yang
Jianqiang Yang
FCFanghui Chen
Fanghui Chen
ZFZhenzhen Fu
Zhenzhen Fu
FYFan Yang
Fan Yang
Nabil SabaNabil Saba
Nabil Saba
Yong TengYong Teng
Yong Teng
Representative flow data showing Thbs2 overexpression (Thbs2 O/E) effect on proliferative (Ki67+) and cytotoxic (GzmB + or IFN-γ+) CD36-CD8+ T cell subsets in MOC2 tumors from wild-type C57BL/6 mice treated with or without CPI-613.

2 June 2025
Verified
Other
Open access
JYJianqiang Yang
Jianqiang Yang
FCFanghui Chen
Fanghui Chen
ZFZhenzhen Fu
Zhenzhen Fu
FYFan Yang
Fan Yang
Nabil SabaNabil Saba
Nabil Saba
Yong TengYong Teng
Yong Teng
Analysis of THBS2 gene expression in normal and tumor tissues using TCGA pan-cancer database.